采用一体化PET/MR比较18F-FDG PET与动脉自旋标记MRI在评估阿尔茨海默病及遗忘型轻度认知障碍中的价值
本研究利用一体化PET/MR比较18F-FDG PET测量的葡萄糖代谢与动脉自旋标记(ASL)MRI测量的脑血流量(CBF)在阿尔茨海默病(AD)和遗忘型轻度认知障碍(aMCI)中的诊断价值。结果显示,AD患者中rCBF与18F-FDG PET SUVR降低区域重叠,而aMCI患者仅18F-FDG PET SUVR降低,rCBF无显著差异;rCBF的meta-ROI ROC分析可诊断AD(AUC 0.87)但不能诊断aMCI(AUC 0.61),联合rCBF与18F-FDG PET SUVR可将aMCI诊断特异性提高至75.56%。结论认为ASL在AD中可检测到与18F-FDG PET相似的异常模式,但在aMCI中不能,18F-FDG PET对AD和aMCI的诊断效能仍高于ASL。
要点
- AD患者中rCBF与18F-FDG PET SUVR降低区域在双侧颞顶叶、额叶皮质和扣带回皮质重叠。
- aMCI患者仅18F-FDG PET SUVR在双侧颞叶皮质、岛叶皮质和额下回皮质降低,rCBF与正常对照无显著差异(P > 0.05)。
- rCBF的meta-ROI ROC分析可诊断AD(AUC 0.87)但不能诊断aMCI(AUC 0.61);联合rCBF与18F-FDG PET SUVR可将aMCI诊断特异性提高至75.56%。
核心结论
- ASL在AD患者中可检测到与18F-FDG PET相似的异常模式,但在aMCI中不能。
- 18F-FDG PET对AD和aMCI患者的诊断效能仍高于ASL。
- 研究结果支持18F-FDG PET可能更适用于诊断AD和aMCI。
研究设计与样本
- 本研究采用一体化PET/MR,比较定量脑血流量(CBF)与18F-FDG PET测量的葡萄糖代谢在AD和aMCI患者中的诊断价值。
主要发现
- 与正常对照(NC)相比,AD患者在双侧颞顶叶区域、额叶皮质和扣带回皮质中rCBF降低与18F-FDG PET SUVR降低存在重叠。
- 与NC相比,aMCI患者仅在双侧颞叶皮质、岛叶皮质和额下回皮质显示18F-FDG PET SUVR降低。
- aMCI患者与NC参与者的rCBF比较无显著差异(P > 0.05)。
- rCBF的meta-ROI ROC分析可诊断AD(AUC 0.87),但不能诊断aMCI(AUC 0.61)。
- 联合rCBF与18F-FDG PET SUVR时,诊断aMCI的特异性提高至75.56%。
关键数值与推荐
- rCBF的meta-ROI诊断AD的AUC为0.87,诊断aMCI的AUC为0.61。
- 联合rCBF与18F-FDG PET SUVR诊断aMCI的特异性为75.56%。
- aMCI患者rCBF与NC比较P > 0.05。
临床怎么用
- 研究结果支持18F-FDG PET可能更适用于诊断AD和aMCI。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Developing biomarkers for early stage AD patients is crucial. Glucose metabolism measured by 18F-FDG PET is the most common biomarker for evaluating cellular energy metabolism to diagnose AD. Arterial spin labeling (ASL) MRI can potentially provide comparable diagnostic information to 18F-FDG PET in patients with neurodegenerative disorders. However, the conclusions about the diagnostic performance of AD are still controversial between 18F-FDG PET and ASL. This study aims to compare quantitative cerebral blood flow (CBF) and glucose metabolism measured by 18F-FDG PET diagnostic values in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI) using integrated PET/MR. RESULTS: Analyses revealed overlapping between decreased regional rCBF and 18F-FDG PET SUVR in patients with AD compared with NC participants in the bilateral parietotemporal regions, frontal cortex, and cingulate cortex. Compared with NC participants, patients with aMCI exclusively demonstrated lower 18F-FDG PET SUVR in the bilateral temporal cortex, insula cortex, and inferior frontal cortex. Comparison of the rCBF in patients with aMCI and NC participants revealed no significant difference (P > 0.05). The ROC analysis of rCBF in the meta-ROI could diagnose patients with AD (AUC, 0.87) but not aMCI (AUC, 0.61). The specificity of diagnosing aMCI has been improved to 75.56% when combining rCBF and 18F-FDG PET SUVR. CONCLUSION: ASL could detect similar aberrant patterns of abnormalities compared to 18F-FDG PET in patients with AD compared with NC participants but not in aMCI. The diagnostic efficiency of 18F-FDG-PET for AD and aMCI patients remained higher to ASL. Our findings support that applying 18F-FDG PET may be preferable for diagnosing AD and aMCI.
引用
- Bi S, Yan S, Chen Z, et al. Comparison of 18F-FDG PET and arterial spin labeling MRI in evaluating Alzheimer's disease and amnestic mild cognitive impairment using integrated PET/MR. EJNMMI Res. 2024. PMID: 38270821. doi:10.1186/s13550-024-01068-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。